Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

Proof-of-concept HIV trial combining novel therapies reports first clinical signs of post-treatment control, opening doors to ...

A new research review to be presented at a pre-congress day for this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2024) will focus on the growing prevalence of HIV ...

*Please mention the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) if using this material* A new research review to be presented at a ...

At a time when science is reimagining what it means to prevent and potentially cure HIV, UAB Microbiology researchers carried their discoveries to the global stage. Angela Wahl, Ph.D., associate ...

There is still no cure or effective vaccine for HIV-1, which remains a public health threat. But scientists have opened up new possibilities in HIV treatment and vaccine development. A Step Towards a ...

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from ...

When human immunodeficiency virus (HIV) emerged and was identified as the cause of acquired immunodeficiency syndrome (AIDS), it was expected that a vaccine would be developed eventually. By over ...

A chronic, survivable condition is better than a death sentence, but it isn’t a cure. This limbo is what HIV patients endure while they are on combined antiretroviral therapy (cART). Unfortunately, ...

NEW YORK, NY, UNITED STATES, July 21, 2025 / EINPresswire.com / -- As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced its new ...